Concepedia

Rolf Güller

RG

Statistics

Publications

10

Citations

465

H-Index

10

Active since

1991

Affiliations

Roche (Switzerland)(Current)

ETH Zurich

Rheinmetall (Switzerland)

Actelion (Switzerland)

Rolf Güller is an author at Roche (Switzerland) specializing in medicinal chemistry, pharmacy, and synthetic medicinal chemistry.

Publications per year

1991–1999

10

Publications

10

Renin inhibition by substituted piperidines: A novel paradigm for the inhibition of monomeric aspartic proteinases?

Christian Oefner, Alfred Binggeli, Volker Breu et al. · Chemistry & Biology · 1999 · 126 citations · Full text

, , +6

Substituted piperidines - highly potent renin inhibitors due to induced fit adaptation of the active site

Eric Vieira, Alfred Binggeli, Volker Breu et al. · Bioorganic & Medicinal Chemistry Letters · 1999 · 95 citations · Full text

, , +16

Piperidine-renin inhibitors compounds with improved physicochemical properties

Rolf Güller, Alfred Binggeli, Volker Breu et al. · Bioorganic & Medicinal Chemistry Letters · 1999 · 69 citations · Full text

, , +14

A Nitroxyl Synthase Catalytic Antibody

Nicolaus Bahr, Rolf Güller, Jean‐Louis Reymond et al. · Journal of the American Chemical Society · 1996 · 45 citations

, , +17

Synthesis of <i>Aristotelia</i>‐Type Alkaloids. Part XII. Total synthesis of (−)‐tasmanine. Stereoelectronic factors that control the rearrangement of 3<i>H</i>‐indol‐3‐ol derivatives to oxindoles ( = 1,3‐dihydro‐2<i>H</i>‐indol‐2‐ones) or to pseudoindoxyls ( =1,2‐dihydro‐3<i>H</i>‐indol‐3‐ones)

Rolf Güller, Hans‐Jürg Borschberg · Helvetica Chimica Acta · 1993 · 41 citations

, , +12

1–5 of 10